Use of Autologous Platelet Concentrate in Macular Hole Surgery: Report of 77 Cases

1997 ◽  
pp. 30-35 ◽  
Author(s):  
A. Gaudric ◽  
M. Paques ◽  
P. Massin ◽  
P.Y. Santiago ◽  
C. Dosquet
Keyword(s):  
Macular Hole ◽  
Platelet Concentrate ◽  
Macular Hole Surgery ◽  
Autologous Platelet Concentrate ◽  
Autologous Platelet

Autologous Platelet Concentrate as an Adjunct in Macular Hole Healing

Ophthalmology ◽  
1996 ◽  
Vol 103 (4) ◽  
pp. 590-594 ◽  
Author(s):  
Jean-François Korobelnik ◽  
Daniele Hannouche ◽  
Nacera Belayachi ◽  
Michel Branger ◽  
Jean-Eric Guez ◽  
...  
Keyword(s):  
Macular Hole ◽  
Platelet Concentrate ◽  
Autologous Platelet Concentrate ◽  
Hole Healing ◽  
Autologous Platelet

Effect of autologous platelet concentrate in surgery for idiopathic macular hole

Ophthalmology ◽  
1999 ◽  
Vol 106 (5) ◽  
pp. 932-938 ◽  
Author(s):  
Michel Paques ◽  
Claude Chastang ◽  
André Mathis ◽  
José Sahel ◽  
Pascale Massin ◽  
...  
Keyword(s):  
Macular Hole ◽  
Platelet Concentrate ◽  
Idiopathic Macular Hole ◽  
Autologous Platelet Concentrate ◽  
Autologous Platelet

Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery

2020 ◽  
pp. 112067212090370 ◽  
Author(s):  
Friederike Schaub ◽  
Nasir Gözlügöl ◽  
Corinna von Goscinski ◽  
Philip Enders ◽  
Ludwig M Heindl ◽  
...  
Keyword(s):  
Macular Hole ◽  
Pars Plana Vitrectomy ◽  
Sulfur Hexafluoride ◽  
Silicone Oil ◽  
Platelet Concentrate ◽  
Heavy Silicone Oil ◽  
Autologous Platelet Concentrate ◽  
Pars Plana ◽  
Autologous Platelet ◽  
Hole Closure

Purpose: Persistence represents the major reason for failure of primary macular hole repair. A variety of surgical approaches are available for treating persistent macular holes. To compare clinical outcome of re-pars plana vitrectomy combined with autologous platelet concentrate and sulfur hexafluoride 20% gas tamponade with heavy silicone oil in persistent macular hole. Methods: Records of 48 consecutive eyes with persistent macular holes which underwent re-pars plana vitrectomy with either heavy silicone oil (35 eyes, persistent macular–hole minimum linear diameter: 518.8 ± 171.1 µm) or autologous platelet concentrate and sulfur hexafluoride 20% (13 eyes, persistent macular hole–minimum linear diameter: 454.1 ± 211.3 µm) were reviewed retrospectively. All patients underwent measurements of anatomical persistent macular hole characteristics evaluated by optical coherence tomography and visual function. Cases in which anatomical success failed after first re-pars plana vitrectomy were treated with the other surgical techniques, comparable to a cross-over design. Results: Persistent macular hole closure rate was 57.1% with autologous platelet concentrate and sulfur hexafluoride 20% and 45.7% with heavy silicone oil ( p = 0.102). Functional results were comparable when persistent macular hole closure was achieved ( p ⩾ 0.741), but significantly better for the autologous platelet concentrate with sulfur hexafluoride 20% group when persistent macular hole closure failed ( p = 0.019). Conclusion: Re-pars plana vitrectomy combined with autologous platelet concentrate and sulfur hexafluoride 20% seems to achieve at least non-inferior persistent macular hole closure rates and comparable functional results when compared to heavy silicone oil, suggesting autologous platelet concentrate and sulfur hexafluoride 20% as a safe surgical alternative in persistent macular hole. Especially when persistent macular hole closure failed, autologous platelet concentrate with sulfur hexafluoride 20% seems to be superior regarding visual outcome.

Autologous platelet concentrate in the treatment of macular holes

1997 ◽  
Vol 94 (12) ◽  
pp. 877-881 ◽  
Author(s):  
F. Faude ◽  
E. Edel ◽  
M. Dannhauer ◽  
C. Petzel ◽  
P. Meier ◽  
...  
Keyword(s):  
Platelet Concentrate ◽  
Macular Holes ◽  
Autologous Platelet Concentrate ◽  
Autologous Platelet
Sign in / Sign up

Export Citation Format

Share Document